Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant.
Hudgens S, Floden L, Blackowicz M, Jamieson C, Popova V, Fedgchin M, Drevets WC, Cooper K, Lane R, Singh J. Hudgens S, et al. Among authors: jamieson c. J Affect Disord. 2021 Feb 15;281:767-775. doi: 10.1016/j.jad.2020.11.066. Epub 2020 Nov 14. J Affect Disord. 2021. PMID: 33261932 Free article. Clinical Trial.
Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant.
Floden L, Hudgens S, Jamieson C, Popova V, Drevets WC, Cooper K, Singh J. Floden L, et al. Among authors: jamieson c. CNS Drugs. 2022 Jun;36(6):649-658. doi: 10.1007/s40263-022-00916-2. Epub 2022 Apr 20. CNS Drugs. 2022. PMID: 35441931 Free PMC article. Clinical Trial.
U.S. Food and Drug Administration's Patient-Focused Drug Development Initiative: Experience with Integration of Patient-Experience Data in a New Drug Application for Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant for Treatment-Resistant Depression.
Katz EG, McNulty P, Levitan B, Treichler P, Martynowicz J, Jamieson C. Katz EG, et al. Among authors: jamieson c. Ther Innov Regul Sci. 2022 Jan;56(1):38-46. doi: 10.1007/s43441-021-00340-6. Epub 2021 Oct 8. Ther Innov Regul Sci. 2022. PMID: 34623613 Free PMC article.
A novel disease specific scale to characterize the symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis: A real-world study.
Azoulai M, Lévy-Heidmann T, Morisseau V, Wilczynski O, Le HH, Jamieson C, Charvet LE, Krupp LB, Lair L. Azoulai M, et al. Among authors: jamieson c. Mult Scler Relat Disord. 2022 Mar;59:103637. doi: 10.1016/j.msard.2022.103637. Epub 2022 Jan 29. Mult Scler Relat Disord. 2022. PMID: 35168093 Free article.
501 results